TARGETING PROLIFERATING CELL NUCLEAR ANTIGEN FOR ENHANCING EFFICACY OF RADIOTHERAPY IN PROSTATE CANCER

$1,164,481FY2022Defense Health AgencyDOD

Cincinnati Univ Of

Investigators